US Cancels Contract With Major COVID-19 Vaccine Manufacturer

The Emergent BioSolutions plant, a manufacturing partner for Johnson & Johnson's COVID-19 vaccine, is seen in Baltimore, Md., on April 9, 2021. Saul Loeb/AFP via Getty Images

The United States government has canceled a contract with Emergent BioSolutions, a major vaccine manufacturer that came under investigation after it was blamed for a bad batch of 15 million doses of Johnson & Johnson’s COVID-19 vaccine.

The Department of Health and Human Services and Emergent mutually agreed to end the contract on Nov. 1, the Maryland-based company said in an earnings report.